Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy.

Di Cosimo S, Appierto V, Pizzamiglio S, Silvestri M, Baselga J, Piccart M, Huober J, Izquierdo M, de la Pena L, Hilbers FS, de Azambuja E, Untch M, Pusztai L, Pritchard K, Nuciforo P, Vincent-Salomon A, Symmans F, Apolone G, de Braud FG, Iorio MV, Verderio P, Daidone MG.

Int J Mol Sci. 2020 Feb 18;21(4). pii: E1386. doi: 10.3390/ijms21041386.

2.

Circulating tumor DNA and disease recurrence in early stage breast cancer: From a case-control study to a prospective longitudinal trial.

Di Cosimo S, Appierto V, Ortolan E, Dell'Angelo F, Silvestri M, Bianchi G, Folli S, De Cecco L, Pruneri G, Daidone MG.

Ann Oncol. 2019 May;30 Suppl 3:iii28-iii29. doi: 10.1093/annonc/mdz096.005. Epub 2020 Jan 8. No abstract available.

PMID:
32084765
3.

Primary tumor somatic mutations in the blood of women with ductal carcinoma in situ of the breast.

Di Cosimo S, Appierto V, Silvestri M, Ortolan E, De Cecco L, Veneroni S, Pruneri G, Vingiani A, Belfiore A, Scaperrotta G, Folli S, Daidone MG.

Ann Oncol. 2020 Mar;31(3):435-437. doi: 10.1016/j.annonc.2019.11.022. Epub 2019 Dec 11. No abstract available.

PMID:
32067686
4.

A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer.

Reduzzi C, Vismara M, Silvestri M, Celio L, Niger M, Peverelli G, De Braud F, Daidone MG, Cappelletti V.

Int J Cancer. 2019 Dec 8. doi: 10.1002/ijc.32822. [Epub ahead of print]

PMID:
31814120
5.

Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity before and after Neoadjuvant Chemotherapy.

Di Cosimo S, Appierto V, Silvestri M, Pruneri G, Vingiani A, Perrone F, Busico A, Folli S, Scaperrotta G, de Braud FG, Bianchi GV, Cavalieri S, Daidone MG, Dugo M.

Cancers (Basel). 2019 Nov 8;11(11). pii: E1753. doi: 10.3390/cancers11111753.

6.

The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells.

Reduzzi C, Vismara M, Gerratana L, Silvestri M, De Braud F, Raspagliesi F, Verzoni E, Di Cosimo S, Locati LD, Cristofanilli M, Daidone MG, Cappelletti V.

Semin Cancer Biol. 2019 Oct 15. pii: S1044-579X(19)30170-1. doi: 10.1016/j.semcancer.2019.10.008. [Epub ahead of print] Review.

7.

Correction: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy.

Petrelli A, Carollo R, Cargnelutti M, Iovino F, Callari M, Cimino D, Todaro M, Mangiapane LR, Giammona A, Cordova A, Montemurro F, Taverna D, Daidone MG, Stassi G, Giordano S.

Oncotarget. 2019 Aug 13;10(48):5003-5004. doi: 10.18632/oncotarget.27151. eCollection 2019 Aug 13.

8.

Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine.

Luchini C, Veronese N, Nottegar A, Cappelletti V, Daidone MG, Smith L, Parris C, Brosens LAA, Caruso MG, Cheng L, Wolfgang CL, Wood LD, Milella M, Salvia R, Scarpa A.

Cancers (Basel). 2019 Aug 10;11(8). pii: E1152. doi: 10.3390/cancers11081152. Review.

9.

Axillary nodal involvement by primary tumor features in early breast cancer: an analysis of 2600 patients.

De Santis MC, La Rocca E, Meneghini E, Bregni G, Di Lorenzo G, Galli G, Di Nicola M, Folli S, Gennaro M, Pruneri G, Paolini B, Daidone MG, De Braud F, Apolone G, Sant M, Di Cosimo S.

Clin Transl Oncol. 2019 Aug 1. doi: 10.1007/s12094-019-02188-7. [Epub ahead of print]

PMID:
31372896
10.

Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) Experience.

Sepe P, Verzoni E, Miodini P, Claps M, Ratta R, Martinetti A, Mennitto R, Sottotetti E, Procopio G, Cappelletti V, Daidone MG.

Cancers (Basel). 2019 Jul 13;11(7). pii: E980. doi: 10.3390/cancers11070980.

11.

The Detection and Morphological Analysis of Circulating Tumor and Host Cells in Breast Cancer Xenograft Models.

Cleris L, Daidone MG, Fina E, Cappelletti V.

Cells. 2019 Jul 5;8(7). pii: E683. doi: 10.3390/cells8070683.

12.

The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study.

Di Cosimo S, Triulzi T, Pizzamiglio S, De Cecco L, de Azambuja E, Fumagalli D, Putzai L, Harbeck N, Izquierdo M, Peña L, Daidone MG, Huober J, Gori S, Cinieri S, Torri V, Baselga J, Piccart M, de Braud FG, Apolone G, Verderio P, Tagliabue E.

Eur J Cancer. 2019 Sep;118:1-9. doi: 10.1016/j.ejca.2019.06.001. Epub 2019 Jul 5.

13.

Plasma miRNA Levels for Predicting Therapeutic Response to Neoadjuvant Treatment in HER2-positive Breast Cancer: Results from the NeoALTTO Trial.

Di Cosimo S, Appierto V, Pizzamiglio S, Tiberio P, Iorio MV, Hilbers F, de Azambuja E, de la Peña L, Izquierdo M, Huober J, Baselga J, Piccart M, de Braud FG, Apolone G, Verderio P, Daidone MG.

Clin Cancer Res. 2019 Jul 1;25(13):3887-3895. doi: 10.1158/1078-0432.CCR-18-2507. Epub 2019 Feb 27.

PMID:
30814109
14.

PATRI, a Genomics Data Integration Tool for Biomarker Discovery.

Ukmar G, Melloni GEM, Raddrizzani L, Rossi P, Di Bella S, Pirchio MR, Vescovi M, Leone A, Callari M, Cesarini M, Somaschini A, Della Vedova G, Daidone MG, Pettenella M, Isacchi A, Bosotti R.

Biomed Res Int. 2018 Jun 28;2018:2012078. doi: 10.1155/2018/2012078. eCollection 2018.

15.

Tailoring treatment of salivary duct carcinoma (SDC) by liquid biopsy: ARv7 expression in circulating tumor cells.

Cappelletti V, Miodini P, Reduzzi C, Alfieri S, Daidone MG, Licitra L, Locati LD.

Ann Oncol. 2018 Jul 1;29(7):1598-1600. doi: 10.1093/annonc/mdy141. No abstract available.

16.

[18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer.

Raccagni I, Belloli S, Valtorta S, Stefano A, Presotto L, Pascali C, Bogni A, Tortoreto M, Zaffaroni N, Daidone MG, Russo G, Bombardieri E, Moresco RM.

PLoS One. 2018 May 23;13(5):e0197754. doi: 10.1371/journal.pone.0197754. eCollection 2018.

17.

Biobanks and scientists: supply and demand.

Paradiso AV, Daidone MG, Canzonieri V, Zito A.

J Transl Med. 2018 May 22;16(1):136. doi: 10.1186/s12967-018-1505-8.

18.

Dynamics of the hazard for distant metastases after ipsilateral breast tumor recurrence according to estrogen receptor status: An analysis of 2851 patients.

Gennaro M, Di Cosimo S, Ardoino I, Veneroni S, Mariani L, Agresti R, Daidone MG, de Braud F, Apolone G, Biganzoli E, Demicheli R.

Breast. 2018 Aug;40:131-135. doi: 10.1016/j.breast.2018.05.004. Epub 2018 May 14.

PMID:
29772517
19.

MicroRNA co-expression patterns unravel the relevance of extra cellular matrix and immunity in breast cancer.

Dugo M, Huang X, Iorio MV, Cataldo A, Tagliabue E, Daidone MG, Wu J, Orlandi R.

Breast. 2018 Jun;39:46-52. doi: 10.1016/j.breast.2018.03.008. Epub 2018 Mar 26.

PMID:
29597130
20.

Metabolic Footprints and Molecular Subtypes in Breast Cancer.

Cappelletti V, Iorio E, Miodini P, Silvestri M, Dugo M, Daidone MG.

Dis Markers. 2017;2017:7687851. doi: 10.1155/2017/7687851. Epub 2017 Dec 24. Review.

21.

Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer.

Callari M, Dugo M, Miodini P, Veneroni S, Bianchini G, Daidone MG, Cappelletti V.

Int J Mol Sci. 2018 Jan 9;19(1). pii: E196. doi: 10.3390/ijms19010196.

22.

Analysis of clonal expansions through the normal and premalignant human breast epithelium reveals the presence of luminal stem cells.

Cereser B, Jansen M, Austin E, Elia G, McFarlane T, van Deurzen CH, Sieuwerts AM, Daidone MG, Tadrous PJ, Wright NA, Jones L, McDonald SA.

J Pathol. 2018 Jan;244(1):61-70. doi: 10.1002/path.4989. Epub 2017 Nov 23.

23.

Polyurethane foam scaffold as in vitro model for breast cancer bone metastasis.

Angeloni V, Contessi N, De Marco C, Bertoldi S, Tanzi MC, Daidone MG, Farè S.

Acta Biomater. 2017 Nov;63:306-316. doi: 10.1016/j.actbio.2017.09.017. Epub 2017 Sep 18.

PMID:
28927931
24.

Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.

Merlino G, Miodini P, Callari M, D'Aiuto F, Cappelletti V, Daidone MG.

Mol Oncol. 2017 Oct;11(10):1399-1412. doi: 10.1002/1878-0261.12107. Epub 2017 Aug 22.

25.

Ten-year results of applying an original scoring system for addressing adjuvant therapy use after breast-conserving surgery for ductal carcinoma in situ of the breast.

Gennaro M, De Santis MC, Mariani L, Lo Vullo S, Cappelletti V, Agresti R, Cortinovis U, Paolini B, Di Cosimo S, Carcangiu ML, Daidone MG, Lozza L.

Breast. 2017 Oct;35:63-68. doi: 10.1016/j.breast.2017.06.010. Epub 2017 Jun 23.

PMID:
28651115
26.

Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors.

Reduzzi C, Motta R, Bertolini G, Miodini P, Martinetti A, Sottotetti E, Daidone MG, Cappelletti V.

Adv Exp Med Biol. 2017;994:83-103. doi: 10.1007/978-3-319-55947-6_4. Review.

PMID:
28560669
27.

Sodium 4-Carboxymethoxyimino-(4-HPR) a Novel Water-Soluble Derivative of 4-Oxo-4-HPR Endowed with In Vivo Anticancer Activity on Solid Tumors.

Tiberio P, Cavadini E, Cleris L, Dallavalle S, Musso L, Daidone MG, Appierto V.

Front Pharmacol. 2017 Apr 26;8:226. doi: 10.3389/fphar.2017.00226. eCollection 2017.

28.

How to study and overcome tumor heterogeneity with circulating biomarkers: The breast cancer case.

Appierto V, Di Cosimo S, Reduzzi C, Pala V, Cappelletti V, Daidone MG.

Semin Cancer Biol. 2017 Jun;44:106-116. doi: 10.1016/j.semcancer.2017.04.007. Epub 2017 Apr 22. Review.

PMID:
28442298
29.

Involvement of AF1q/MLLT11 in the progression of ovarian cancer.

Tiberio P, Lozneanu L, Angeloni V, Cavadini E, Pinciroli P, Callari M, Carcangiu ML, Lorusso D, Raspagliesi F, Pala V, Daidone MG, Appierto V.

Oncotarget. 2017 Apr 4;8(14):23246-23264. doi: 10.18632/oncotarget.15574.

30.

Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods.

Fina E, Necchi A, Bottelli S, Reduzzi C, Pizzamiglio S, Iacona C, Daidone MG, Verderio P, Cappelletti V.

Dis Markers. 2017;2017:3414910. doi: 10.1155/2017/3414910. Epub 2017 Feb 22.

31.

Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial Carcinoma.

Fina E, Necchi A, Giannatempo P, Colecchia M, Raggi D, Daidone MG, Cappelletti V.

Bladder Cancer. 2016 Oct 27;2(4):395-403. doi: 10.3233/BLC-160069.

32.

Quality Matters: 2016 Annual Conference of the National Infrastructures for Biobanking.

Doucet M, Becker KF, Björkman J, Bonnet J, Clément B, Daidone MG, Duyckaerts C, Erb G, Haslacher H, Hofman P, Huppertz B, Junot C, Lundeberg J, Metspalu A, Lavitrano M, Litton JE, Moore HM, Morente M, Naimi BY, Oelmueller U, Ollier B, Parodi B, Ruan L, Stanta G, Turano P, Vaught J, Watson P, Wichmann HE, Yuille M, Zaomi M, Zatloukal K, Dagher G.

Biopreserv Biobank. 2017 Jun;15(3):270-276. doi: 10.1089/bio.2016.0053. Epub 2016 Dec 19. No abstract available.

33.

A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer.

Humphries MP, Sundara Rajan S, Droop A, Suleman CAB, Carbone C, Nilsson C, Honarpisheh H, Cserni G, Dent J, Fulford L, Jordan LB, Jones JL, Kanthan R, Litwiniuk M, Di Benedetto A, Mottolese M, Provenzano E, Shousha S, Stephens M, Walker RA, Kulka J, Ellis IO, Jeffery M, Thygesen HH, Cappelletti V, Daidone MG, Hedenfalk IA, Fjällskog ML, Melisi D, Stead LF, Shaaban AM, Speirs V.

Clin Cancer Res. 2017 May 15;23(10):2575-2583. doi: 10.1158/1078-0432.CCR-16-1952. Epub 2016 Dec 16.

34.

A trans-platinum(II) complex induces apoptosis in cancer stem cells of breast cancer.

Aztopal N, Karakas D, Cevatemre B, Ari F, Icsel C, Daidone MG, Ulukaya E.

Bioorg Med Chem. 2017 Jan 1;25(1):269-276. doi: 10.1016/j.bmc.2016.10.032. Epub 2016 Oct 29.

PMID:
27839660
35.

Stromal Activation by Tumor Cells: An in Vitro Study in Breast Cancer.

Merlino G, Miodini P, Paolini B, Carcangiu ML, Gennaro M, Dugo M, Daidone MG, Cappelletti V.

Microarrays (Basel). 2016 May 18;5(2). pii: E10. doi: 10.3390/microarrays5020010.

36.

Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.

Baroni S, Romero-Cordoba S, Plantamura I, Dugo M, D'Ippolito E, Cataldo A, Cosentino G, Angeloni V, Rossini A, Daidone MG, Iorio MV.

Cell Death Dis. 2016 Jul 28;7(7):e2312. doi: 10.1038/cddis.2016.224.

37.

Applicability of Under Vacuum Fresh Tissue Sealing and Cooling to Omics Analysis of Tumor Tissues.

Veneroni S, Dugo M, Daidone MG, Iorio E, Valeri B, Pinciroli P, De Bortoli M, Marchesi E, Miodini P, Taverna E, Ricci A, Canevari S, Pelosi G, Bongarzone I.

Biopreserv Biobank. 2016 Dec;14(6):480-490. Epub 2016 Jul 12.

PMID:
27403896
38.

Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma.

Gasparini P, Casanova M, Villa R, Collini P, Alaggio R, Zin A, Bonvini P, Antonescu CR, Boldrini R, Caserini R, Moro M, Centonze G, Meazza C, Massimino M, Bergamaschi L, Luksch R, Chiaravalli S, Bisogno G, Zaffaroni N, Daidone MG, Sozzi G, Ferrari A.

Oncotarget. 2016 Sep 13;7(37):58903-58914. doi: 10.18632/oncotarget.10368.

39.

Water-soluble derivatives of 4-oxo-N-(4-hydroxyphenyl) retinamide: synthesis and biological activity.

Musso L, Tiberio P, Appierto V, Cincinelli R, Cavadini E, Cleris L, Daidone MG, Dallavalle S.

Chem Biol Drug Des. 2016 Oct;88(4):608-14. doi: 10.1111/cbdd.12781. Epub 2016 Jun 6.

PMID:
27135197
40.

Waiting for Godot: Predictive factors for adjuvant treatment of patients with luminal breast cancer.

Di Cosimo S, Bregni G, Daidone MG, Cinquini M, de Braud F, Torri V.

Breast. 2016 Jun;27:187-8. doi: 10.1016/j.breast.2016.02.002. Epub 2016 Apr 23. No abstract available.

PMID:
27118634
41.

Proposal of supervised data analysis strategy of plasma miRNAs from hybridisation array data with an application to assess hemolysis-related deregulation.

Landoni E, Miceli R, Callari M, Tiberio P, Appierto V, Angeloni V, Mariani L, Daidone MG.

BMC Bioinformatics. 2015 Nov 18;16:388. doi: 10.1186/s12859-015-0820-9.

42.

In-depth characterization of breast cancer tumor-promoting cell transcriptome by RNA sequencing and microarrays.

Callari M, Guffanti A, Soldà G, Merlino G, Fina E, Brini E, Moles A, Cappelletti V, Daidone MG.

Oncotarget. 2016 Jan 5;7(1):976-94. doi: 10.18632/oncotarget.5810.

43.

Subtype-Specific Metagene-Based Prediction of Outcome after Neoadjuvant and Adjuvant Treatment in Breast Cancer.

Callari M, Cappelletti V, D'Aiuto F, Musella V, Lembo A, Petel F, Karn T, Iwamoto T, Provero P, Daidone MG, Gianni L, Bianchini G.

Clin Cancer Res. 2016 Jan 15;22(2):337-45. doi: 10.1158/1078-0432.CCR-15-0757. Epub 2015 Sep 30.

44.

Tumor-extracellular matrix interactions: Identification of tools associated with breast cancer progression.

Giussani M, Merlino G, Cappelletti V, Tagliabue E, Daidone MG.

Semin Cancer Biol. 2015 Dec;35:3-10. doi: 10.1016/j.semcancer.2015.09.012. Epub 2015 Sep 28. Review.

45.

Did circulating tumor cells tell us all they could? The missed circulating tumor cell message in breast cancer.

Fina E, Reduzzi C, Motta R, Di Cosimo S, Bianchi G, Martinetti A, Wechsler J, Cappelletti V, Daidone MG.

Int J Biol Markers. 2015 Nov 11;30(4):e429-33. doi: 10.5301/jbm.5000166.

PMID:
26349664
46.

Optimizing sharing of hospital biobank samples.

Riegman PH, de Jong B, Daidone MG, Söderström T, Thompson J, Hall JA, Mendy M, Ten Hoeve J, Broeks A, Reed W, Morente MM, López-Guerrero JA, Collins VP, Rogan J, Ringborg U.

Sci Transl Med. 2015 Jul 22;7(297):297fs31. doi: 10.1126/scitranslmed.3009279.

PMID:
26203078
47.

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013).

Amoroso V, Generali D, Buchholz T, Cristofanilli M, Pedersini R, Curigliano G, Daidone MG, Di Cosimo S, Dowsett M, Fox S, Harris AL, Makris A, Vassalli L, Ravelli A, Cappelletti MR, Hatzis C, Hudis CA, Pedrazzoli P, Sapino A, Semiglazov V, Von Minckwitz G, Simoncini EL, Jacobs MA, Barry P, Kühn T, Darby S, Hermelink K, Symmans F, Gennari A, Schiavon G, Dogliotti L, Berruti A, Bottini A.

J Natl Cancer Inst Monogr. 2015 May;2015(51):90-6. doi: 10.1093/jncimonographs/lgv023.

48.

Circulating Biomarkers for Prediction of Treatment Response.

Cappelletti V, Appierto V, Tiberio P, Fina E, Callari M, Daidone MG.

J Natl Cancer Inst Monogr. 2015 May;2015(51):60-3. doi: 10.1093/jncimonographs/lgv006.

PMID:
26063889
49.

miR-30e* is an independent subtype-specific prognostic marker in breast cancer.

D'Aiuto F, Callari M, Dugo M, Merlino G, Musella V, Miodini P, Paolini B, Cappelletti V, Daidone MG.

Br J Cancer. 2015 Jul 14;113(2):290-8. doi: 10.1038/bjc.2015.206. Epub 2015 Jun 9.

50.

A breast cancer clinical registry in an Italian comprehensive cancer center: an instrument for descriptive, clinical, and experimental research.

Baili P, Torresani M, Agresti R, Rosito G, Daidone MG, Veneroni S, Cavallo I, Funaro F, Giunco M, Turco A, Amash H, Scavo A, Minicozzi P, Bella F, Meneghini E, Sant M.

Tumori. 2015 Jul-Aug;101(4):440-6. doi: 10.5301/tj.5000341. Epub 2015 May 2.

PMID:
25953447

Supplemental Content

Loading ...
Support Center